Penile Girth Augmentation Cost: An Evidence Review of Fat, Filler and Silicone

Why This Page Is Candid About the Evidence

Patients who search for penis enlargement surgery cost will find price lists from clinics and aggregators. They rarely find what the professional societies have said about the same procedures. For a procedure that is elective, mostly irreversible in practice and paid for out of pocket, the evidence belongs next to the price. This page sets both side by side. It describes what each option involves, what the published literature reports, what each society has stated, what regulators have and have not cleared, and who should be counseled first. It does not recommend any of the procedures.

The Three Options Compared

No published national price data exist for these procedures; bands are editorial estimates consistent with this site’s fat transfer, hyaluronic acid and silicone implant pages.

What Professional Bodies Say

Three positions bear directly on these procedures. Each is attributed only as far as the source text supports.

• American Urological Association. The AUA’s statement on penile augmentation surgery says that injecting fat under the skin to increase girth, and cutting the suspensory ligament to lengthen the penis in adults, have not been shown to be safe or effective. The statement was first adopted in 1994 and most recently reaffirmed in October 2018. It does not address fillers or silicone sleeves.
• European Association of Urology. The EAU’s 2023 guidelines on penile size abnormalities and dysmorphophobia (summarized in European Urology Focus, 2024) classify abnormalities as congenital, acquired or dysmorphophobic. They state that surgery to increase length or girth has limited evidence and should be offered only after thorough counseling, and that men with normal penile size seeking augmentation should be referred for psychological evaluation for possible dysmorphophobic disorder.
• Sexual Medicine Society of North America. The SMSNA position statement (Journal of Sexual Medicine, 2024) says hyaluronic acid and polylactic acid fillers show potential benefit with an acceptable safety profile on limited data, and urges that they be studied under institutional review board (IRB)-approved protocols. It strongly recommends against permanent filler materials, including paraffin and silicone. It recommends against graft-and-flap procedures outside a research protocol. For silicone sleeve implants it calls for investigational status, IRB oversight, long-term safety endpoints and use only by experienced surgeons after counseling about severe complications. It also states that penile dysmorphic disorder must be ruled out before invasive treatment.

The three statements do not agree on every point, and they are expert opinion based on limited literature, as the SMSNA authors acknowledge. They agree on two things: the evidence base is thin, and psychological assessment comes first.

Autologous Fat Transfer

Fat transfer uses the patient’s own adipose tissue. It avoids a manufactured implant but requires a separate harvest procedure, and the band reflects both. See penile girth augmentation by fat transfer for the technique.

What was measured. A retrospective study of 52 men with thin penises (Aesthetic Plastic Surgery, 2012) reported a mean girth gain of about 2.3 cm at six months after injection of a mean of 38.5 mL of fat, no change in length, stable erectile function scores and one case of nodular fat (1.9%). It was a single-group retrospective study with short follow-up. A 2026 retrospective, non-randomized comparison of 50 men treated with stromal vascular fraction-enriched fat and 38 treated with conventional (Coleman) fat reported flaccid girth gains at 12 months of 2.8 cm and 1.6 cm respectively, with minor wound infections in two men in each group. That comparison suggests retention varies with processing technique, but it is a single early study.

Resorption and repeat sessions. Grafted fat is partly resorbed. Penile-specific retention figures are inconsistently reported. For context, a pooled analysis of facial fat grafting (not penile) found average retention of 47% across 27 studies, with individual studies ranging from 26% to 83%, and the measurement method significantly affected the figure. Planning for more than one session is therefore reasonable, and the cost should be framed accordingly.

Complications. Nodularity and contour irregularity are the commonly cited problems. A rare but severe event is documented in a forensic case report of sudden death from fat embolism after penile fat injection, in a man who had earlier had penile elongation surgery. A single case does not establish a rate, but it is why prior penile surgery must be disclosed.

Hyaluronic Acid Filler

Hyaluronic acid is injected as a filler around the shaft; see hyaluronic acid penile enhancement. It is the lowest-cost option and the one that is absorbed over time.

What was measured. A systematic review of nonsurgical augmentation (Dermatologic Surgery, 2021) included 13 studies and 1,311 patients; hyaluronic acid was the most commonly described agent (4 articles, 205 patients), with mean injected volumes ranging from 20 to 40 mL. A minority of patients in all studies had side effects, and some had disabling complications; the authors called for randomized trials. A 2023 meta-analysis of four studies (283 participants) comparing hyaluronic acid with polylactic acid favored hyaluronic acid for girth and sexual satisfaction at 12 weeks, with no difference in pain or inflammation. A randomized, double-blind trial summarized in a 2024 systematic review enrolled 74 men with 18 months of follow-up: both agents increased girth, and injection-associated adverse events occurred in 9.1% of the hyaluronic acid group and 5.9% of the polylactic acid group, with no serious adverse events.

Durability. The longest controlled follow-up in these sources is 18 months, which is a follow-up endpoint, not a measurement of how long results last. Because hyaluronic acid is absorbed over time, ask for the surgeon’s retreatment schedule and price in writing.

Regulatory status. The FDA’s dermal filler page lists approved uses of temporary fillers as facial wrinkles and folds, lips, cheeks, chin and the back of the hand. Penile augmentation is not among them, so penile use is off-label. The FDA states that the risks of unapproved uses are not known, and identifies unintentional injection into a blood vessel as the most serious risk of fillers in general. The same page states that injectable silicone is not approved for any aesthetic use, which is consistent with the SMSNA recommendation against permanent injectable fillers.

Silicone Sleeve Implants

A preformed silicone sleeve is placed surgically under the penile skin; see silicone penile implant. It is the most expensive of the three and the only one intended as a permanent device. It differs fundamentally from the penile prosthesis used to treat erectile dysfunction, which is placed inside the corpora cavernosa and is often insurance-covered.

What was measured. A 2026 systematic review and meta-analysis of subcutaneous silicone sleeve implants (International Journal of Impotence Research) included 12 publications and pooled four cohort studies. Pooled flaccid girth gain was 3.77 cm. Pooled complication rates were 3.03% for infection, 5.03% for seroma, 5.12% for erosion or exposure, 3.53% for revision and 7.08% for explantation. The authors note that the data describe flaccid dimensions only and that erect measurements and patient-reported outcomes were limited. A broader 2024 systematic review of augmentation techniques reported removal rates of 3% to 10% in the sleeve series it examined, one of them a 400-patient series authored by the surgeon named as the contact on the FDA clearances below.

Regulatory status. The FDA’s 510(k) database lists several clearances under the product code for silicone block (elastomer), including “Pre-Formed Penile Silicone Block” (K162624 in 2017, K181387 in 2019 and K220760 in 2022) held by International Medical Devices, Inc., and a separate “AugMENTA Penile Implant” (K200073, 2022). All were substantially equivalent determinations through the traditional 510(k) pathway. A 510(k) is clearance based on equivalence to an earlier device, not premarket approval of safety and effectiveness for a specific cosmetic claim. Brand names such as Penuma and Himplant do not appear in the FDA’s device-name field, and the database summary does not reproduce the cleared indication, so ask the surgeon for the 510(k) number of the exact device and the cleared indication. SMSNA’s investigational classification is a separate matter from FDA clearance.

What You Pay Over Time

The headline band understates the cost of options that need repeating. The arithmetic below is illustrative and uses the bands above; it is not a quote.

Retreatment and second-session assumptions are illustrative; published data on how often they are needed are limited.

None of these procedures is a covered benefit under the insurer policies reviewed for this site. Those policies address penile prostheses for erectile dysfunction, not cosmetic girth augmentation, so treat these procedures as cash-pay and confirm with your plan.

Who Should Be Counseled First, or Decline

A review of men who seek penile augmentation surgery (Sexual Medicine Reviews, 2022) found that they usually have normal penile dimensions, that published data on lengthening and girth procedures are limited, and that structured psychological counseling remains the recommended first-line care. The authors noted that men who undergo enhancement are often dissatisfied and may develop complications, and that social pressure can contribute to penile dysmorphic disorder and small penis anxiety.

• Normal-size anatomy with persistent distress. The EAU recommends psychological evaluation for possible dysmorphophobic disorder before augmentation. The SMSNA advises standardized screening questionnaires and professional assessment, and says the disorder must be ruled out before invasive treatment. A surgeon who does not ask about this has not followed either body.
• Uncontrolled psychological conditions. The SMSNA advises deferring invasive treatment until a mental health professional has cleared the patient.
• Prior penile surgery or injections. Tell the surgeon about every earlier procedure and any injected material; the fatal embolism case involved earlier elongation surgery.
• Erectile dysfunction as the real concern. Girth procedures do not treat it. A man whose goal is reliable erections should see the inflatable penile prosthesis or medical options instead.

Questions to Ask a Surgeon

• Is this procedure offered under a research protocol with IRB oversight, as the SMSNA recommends for fillers and sleeve implants? If not, why not?
• What is your own outcome data: girth gain at 6 and 12 months, how it was measured, complication rate and removal or retreatment rate?
• For a silicone sleeve: what is the 510(k) number of the device, what is its cleared indication, and what does removal cost?
• For filler: which product, what volume, what is that product’s FDA-approved indication, and is hyaluronidase immediately available?
• For fat: how is the fat processed, how do you measure retention, and how many sessions do your patients typically need?
• Will I be screened for penile dysmorphic disorder, and would you decline to operate if the result were positive?
• What does the fee include, and what is the policy if a complication needs treatment? See our credential standard and the guide to urologist credentials.

Sources

1. Pignanelli M, Williams JM, Fernandez Crespo RE, Britt J, Parker J, Carrion R. Complications and management of penile enhancement procedures. Transl Androl Urol. 2025;14(10):3367-3376. doi:10.21037/tau-23-519. PMC12603848. Source for the American Urological Association position on penile augmentation as reported in this review.
2. Falcone M, Bettocchi C, Carvalho J, et al. European Association of Urology guidelines on penile size abnormalities and dysmorphophobia: summary of the 2023 guidelines. Eur Urol Focus. 2024;10(3):432–441. PubMed 37709592
3. Trost L, Watter DN, Carrier S, et al. Cosmetic penile enhancement procedures: an SMSNA position statement. J Sex Med. 2024;21(6):573–578. DOI 10.1093/jsxmed/qdae045. academic.oup.com
4. Falagario UG, Piramide F, Pang KH, et al. Techniques for penile augmentation surgery: a systematic review of surgical outcomes, complications, and quality of life. Medicina (Kaunas). 2024;60(5):758. PMC11123079
5. Salloum A, Bazzi N, Haber R. Nonsurgical methods for penile augmentation: a systematic review. Dermatol Surg. 2021;47(3):e81–e85. PubMed 33587382
6. Kusumaputra A, Setiawan MR, Soebadi MA, Wirjopranoto S. Efficacy and complications of hyaluronic acid and polylactic acid for penile augmentation: a systematic review and meta-analysis. Ann Med Surg (Lond). 2023;85(9):4531–4538. PubMed 37663705
7. Kang DH, Chung JH, Kim YJ, et al. Efficacy and safety of penile girth enhancement by autologous fat injection for patients with thin penises. Aesthetic Plast Surg. 2012;36(4):813–818. PubMed 22527585
8. Ivanenko O, Gheiler E, Sforza M. Superior penile girth retention with stromal vascular fraction-enriched autologous fat grafting: a retrospective one-year comparative study. Transl Androl Urol. 2026. PubMed 42582889
9. Lv Q, Li X, Qi Y, et al. Volume retention after facial fat grafting and relevant factors: a systematic review and meta-analysis. Aesthetic Plast Surg. 2021;45(2):506–520. (Facial data, cited for context only.) PubMed 31940073
10. Zilg B, Råsten-Almqvist P. Fatal fat embolism after penis enlargement by autologous fat transfer: a case report and review of the literature. J Forensic Sci. 2017;62(5):1383–1385. PubMed 28749069
11. Yang H, Xiao W, Wang H, Tang G. Subcutaneous penile silicone sleeve implants for penile augmentation: a systematic review and meta-analysis. Int J Impot Res. 2026. DOI 10.1038/s41443-026-01368-8. PubMed 42834144
12. Soubra A, Natale C, Brimley S, Hellstrom WJG. Revelations on men who seek penile augmentation surgery: a review. Sex Med Rev. 2022;10(3). DOI 10.1016/j.sxmr.2021.10.003. PubMed 34896063
13. U.S. Food and Drug Administration. Dermal fillers (soft tissue fillers). fda.gov
14. U.S. Food and Drug Administration. 510(k) Premarket Notification database, product code MIB (elastomer, silicone block); record K220760, Pre-Formed Penile Silicone Block. accessdata.fda.gov

Cost figures are ranges and editorial estimates unless a source above states otherwise. This article is educational and is not medical advice.